Wound Care - Central & Western Europe

  • Central & Western Europe
  • In Central & Western Europe, the Wound Care market market generated a revenue of US$0.70bn in 2024.
  • It is projected to experience an annual growth rate of 0.28% (CAGR 2024-2029).
  • When compared to other regions worldwide, the in the United States leads in revenue generation, reaching US$1,052.00m in 2024.
  • In terms of per capita figures, the revenue per person amounted to US$2.08 in 2024.
  • In Central & Western Europe, Germany is leading the way in the development of advanced wound care products, with a focus on innovation and quality.

Key regions: Europe, United Kingdom, United States, Japan, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Central & Western Europe is experiencing significant growth due to several factors.

Customer preferences:
Customers in Central & Western Europe are increasingly seeking advanced wound care products that offer faster healing and improved patient comfort. They are also becoming more conscious of the importance of infection prevention and are demanding wound care products that have antimicrobial properties. Additionally, there is a growing preference for products that are easy to use and require minimal maintenance.

Trends in the market:
One of the key trends in the Wound Care market in Central & Western Europe is the increasing adoption of advanced wound dressings. These dressings are designed to promote faster healing and provide better protection against infection. They are made from innovative materials that can absorb excess moisture, maintain a moist wound environment, and facilitate the healing process. The demand for advanced wound dressings is being driven by the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the increasing aging population in the region.Another trend in the market is the growing popularity of negative pressure wound therapy (NPWT). NPWT is a non-invasive technique that uses a vacuum system to promote wound healing. It helps to remove excess fluid from the wound, reduce swelling, and improve blood flow to the area. NPWT is particularly effective for treating complex wounds, such as those caused by trauma or surgery. The increasing adoption of NPWT in Central & Western Europe can be attributed to its proven efficacy and the growing awareness among healthcare professionals about its benefits.

Local special circumstances:
Central & Western Europe has a well-established healthcare infrastructure and a high level of healthcare expenditure. This enables healthcare providers in the region to invest in advanced wound care technologies and products. Additionally, the region has a strong focus on research and development, which has led to the development of innovative wound care solutions. The presence of leading wound care companies in countries like Germany, France, and the United Kingdom further contributes to the growth of the market in Central & Western Europe.

Underlying macroeconomic factors:
The growth of the Wound Care market in Central & Western Europe is also influenced by underlying macroeconomic factors. The region has a stable economy and a high standard of living, which allows individuals to afford quality healthcare services and products. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and obesity, is driving the demand for wound care products. These factors, combined with the aging population and the rising healthcare expenditure, are expected to continue fueling the growth of the Wound Care market in Central & Western Europe in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)